Ep 24: SECOMBIT
Melanoma Matters14 Okt 2024

Ep 24: SECOMBIT

Summary

James is ill (apparent in his voice)! Find out what gets James to show up to an ASCO meeting, and stay tuned for the fact check to hear the infamous tweet from Omid Hamid regarding James' scrubs.

In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel discuss sequencing of immunotherapy and targeted therapy for BRAF-positive melanoma. They review the SECOMBIT study 4-year update from Nature Communications. The sandwich approach is unpacked as an approach to debulk the tumor and increase immune fitness of the patient. They also review lactate dehydrogenase as a selection criteria for treatment, the role of LDH, the phrase 'par excellence', the difference in impact factor between Nature journals, CNS incidence and autopsy series.


Keywords

SECOMBIT trial, BRAF positive melanoma, lactate dehydrogenase, LDH, immunotherapy, targeted therapy, CNS incidence, autopsy series


Titles

The Role of LDH

CNS Incidence and Autopsy Series


Sound Bites

"You're rocking the scrubs"

"How to define par excellence"

"Difference in impact factor"



Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(88)

Ep 84: Merlin CP-GEP and Castle i31-SLNB tests

Ep 84: Merlin CP-GEP and Castle i31-SLNB tests

In this episode, the chin dimple is front and center. James explains the wizarding home of Tintagel in Cornwall to Sapna, situated on a lovely promontory. This episode explores the latest evidence on ...

24 Jul 0s

Ep 83: Guest Megan Othus and Time of Day Administration

Ep 83: Guest Megan Othus and Time of Day Administration

James and Sapna welcome Megan Othus, Professor of Biostatistics at the Fred Hutch Cancer Center and one of the key statisticians at SWOG.Megan talks about growing up in the PNW and going East to get b...

24 Jun 40min

Ep 82: Best of ASCO: 2026

Ep 82: Best of ASCO: 2026

In this episode, James & Sapna tease the size of ASCO and ESMO and number of simultaneous publications.They review the most impactful melanoma and Merkel cell carcinoma presentations from ASCO 2026, f...

13 Jun 1h 4min

Live from ASCO 2026: a preview

Live from ASCO 2026: a preview

James & Sapna sent a brief message from ASCO 2026 about what they are looking forward to hearing at the meeting.OptimUM-02ADAMKN-942Neoadjuvant pilot studies... and more

1 Jun 6min

Ep 81: IGNYTE trial (RP1 + nivo)

Ep 81: IGNYTE trial (RP1 + nivo)

SummaryThe conversation covers the published data from the IGNYTE study - RP1 + nivolumab: response rate and safety profile, RNA-seq analysis, and toxicity. The key takeaways include insights into cli...

13 Feb 32min

Ep 80: 2025 Holiday Special

Ep 80: 2025 Holiday Special

SummaryHappy Holidays and Festive Season Everyone! In this episode of Melanoma Matters, hosts Sapna Patel and James reflect on their "cultural" experiences over the past year, discussing movies, music...

30 Des 202535min

Ep 79: coBRIM, COMBI-d 5-year follow-up

Ep 79: coBRIM, COMBI-d 5-year follow-up

SummaryIn this episode of Melanoma Matters, James awaits an invitation to a film premiere (The Penguin Lessons) and we all await a picture of him in his tuxedo! Sapna and James go on to discuss the 5-...

29 Des 202536min

Ep 78 TRAILER: MEK inhibitor trials

Ep 78 TRAILER: MEK inhibitor trials

Enjoy this short trailer on MEK inhibitor monotherapy trials in melanoma

29 Des 20251min

Populært innen Helse

fastlegen
hvordan-har-du-det-mann
rss-gukild-johaug
lydartikler-fra-aftenposten
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
rss-garne-damer
foreldreradet
morten-ramm-lar-kakla-ga-til-du-sovner
hjernesterk
klimaks
g-punktet
rss-skravla-gar
rss-kunsten-a-leve
sinnsyn
hverdagspsyken
biohacking-girls-din-podcast-for-optimal-helse
helsetipspodden